Pituitary tumor-transforming 1 pseudogene 2 (PTTG1P2)

PTTG1 pseudogene 2 (PTTG1P2), also known as pituitary tumor-transforming 1 pseudogene 2, is a **pseudogene** related to the PTTG (pituitary tumor-transforming gene) family. While the PTTG family includes protein-coding genes (PTTG1 and PTTG2) involved in regulating the cell cycle, sister chromatid separation, and oncogenesis, PTTG1P2 itself is a pseudogene and not known to encode a functional protein or have a direct biological function. Currently, there is no evidence that PTTG1P2 acts as a therapeutic target, biomarker, or has interacting drugs. Studies focusing on the PTTG family primarily discuss PTTG1, PTTG2, and PTTG3P as functionally significant, but PTTG1P2 is not highlighted in this context[1][3]. **Clarification:** - PTTG1P2 appears to be an incorrect or irrelevant entry as a target molecule/receptor for therapeutic intervention. Scientific literature recognizes *PTTG1* (securin) and *PTTG2* (a securin-related protein) as protein-encoding family members with oncogenic roles, whereas PTTG1P2 is a non-coding pseudogene and hence not considered a drug target, biological receptor, or enzyme[1][3]. - No molecular function, disease association, or interaction data is available for PTTG1P2; information on PTTG1 and PTTG2 **should not be conflated** with PTTG1P2[1][3].

Other names

PTTG1 regulator of sister chromatid separation, securin pseudogenepituitary tumor-transforming 1 pseudogenePTTG1P2